GABOXADOL

Gaboxadol is a GABA‑A receptor agonist that enhances inhibitory neurotransmission, producing sedative and hypnotic effects. It has been studied for insomnia. Side effects include drowsiness, dizziness, confusion, and potential dependence.

SKU: 3dfbd185cd2d Category: Tag:

Product Description


Mechanism of Action

Gaboxadol (THIP) is a potent GABA‑A receptor agonist with selectivity for extrasynaptic δ‑subunit‑containing receptors, producing sustained tonic inhibitory currents. This distinguishes its sedative and hypnotic profile from benzodiazepines, which primarily enhance synaptic GABA‑A activity.

Benefits and Advantages

Used in sleep‑state regulation research, tonic‑inhibition modelling, receptor‑subtype pharmacology and CNS drug‑development assays.

Side Effects and Risks

Risks include drowsiness, dizziness, confusion, altered sleep architecture and, at high doses, respiratory and CNS depression. Handle with CNS‑depressant precautions.

Datasheet


Molecular Formula

C7H10N2O2

Molecular Weight

140.14 g/mol

CAS Number

64603-91-4

Storage Condition

Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light.

Solubility

Solubility depends on solvent and conditions (e.g., pH). Please contact us for solvent-specific guidance.

Purity

Purity information is available upon request (COA).

Synonym

gaboxadol; THIP; 64603-91-4; Gaboxadolum; MK-0928

IUPAC/Chemical Name

4,5,6,7-tetrahydro-[1,2]oxazolo[5,4-c]pyridin-3-one

InChl Key

ZXRVKCBLGJOCEE-UHFFFAOYSA-N

InChl Code

InChI=1S/C6H8N2O2/c9-6-4-1-2-7-3-5(4)10-8-6/h7H,1-3H2,(H,8,9)

References

https://pubchem.ncbi.nlm.nih.gov/compound/3448;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download